Exploring the efficacy and mechanism of action of combined pan-Raf and MEK inhibition in halting the growth of non-V600 BRAF mutated tumors.

Authors: Islam E. Elkholi, Sara Fraser, Marco Biondini, Emmanuelle Rousselle, Sarah M. Maritan, Jennifer Maxwell, Matthew G. Annis, Peter M. Siegel, Anna Spreafico, David W. Cescon, April A. N. Rose

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.3117

Source: Full article

---

Abstract

3117